Pastāsti draugiem par šo preci:
Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition
Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
158 pages, 11 Tables, color; 14 Illustrations, color; 4 Illustrations, black and white; XIII, 158 p.
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2019. gada 8. janvāris |
| ISBN13 | 9783030086527 |
| Izdevēji | Springer Nature Switzerland AG |
| Lapas | 158 |
| Izmēri | 150 × 220 × 10 mm · 254 g |
| Valoda | Vācu |
| Redaktors | Chatal, Jean-Francois |
| Redaktors | Hosono, Makoto |
Ziemassvētku dāvanas var atgriezt līdz 31. janvārim